{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T10:54:26Z","timestamp":1794912866830,"version":"4.9.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"21","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T00:00:00Z","timestamp":1649030400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000278","name":"Department for International Development, UK Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000278","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["MR\/R015600\/1"],"award-info":[{"award-number":["MR\/R015600\/1"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["200861\/Z\/16\/Z"],"award-info":[{"award-number":["200861\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.vaccine.2022.03.065","type":"journal-article","created":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T17:31:53Z","timestamp":1649439113000},"page":"2940-2948","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Is annual vaccination best? A modelling study of influenza vaccination strategies in children"],"prefix":"10.1016","volume":"40","author":[{"given":"Kylie E.C.","family":"Ainslie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Riley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2022.03.065_b0005","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0140-6736(17)33293-2","article-title":"Estimates of global seasonal influenza-associated respiratory mortality: a modelling study","volume":"391","author":"Iuliano","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2022.03.065_b0010","unstructured":"European Scientific Working Group on Influenza. Bringing childhood flu vaccination to the next level: report and roadmap to actions. ESWI Flu Summit; 2018."},{"key":"10.1016\/j.vaccine.2022.03.065_b0015","unstructured":"World Health Organization. Influenza (Seasonal); 2017."},{"key":"10.1016\/j.vaccine.2022.03.065_b0020","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1097\/INF.0b013e3181fe37c8","article-title":"Incidence of influenza-related hospitalizations in different age groups of children in Finland: a 16-year study","volume":"30","author":"Silvennoinen","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2022.03.065_b0025","unstructured":"Van-Tam J, Cosford P, Powis S. Annual National Flu programme letter 2019 to 2020; 2019."},{"key":"10.1016\/j.vaccine.2022.03.065_b0030","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.epidem.2015.04.003","article-title":"On the relative role of different age groups in influenza epidemics","volume":"13","author":"Worby","year":"2015","journal-title":"Epidemics"},{"key":"10.1016\/j.vaccine.2022.03.065_b0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001527","article-title":"Assessing optimal target populations for influenza vaccination programmes: an evidence synthesis and modelling study","volume":"10","author":"Baguelin","year":"2013","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2022.03.065_b0040","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.epidem.2018.10.003","article-title":"Vaccinating children against influenza increases variability in epidemic size","volume":"26","author":"Backer","year":"2019","journal-title":"Epidemics"},{"key":"10.1016\/j.vaccine.2022.03.065_b0045","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1098\/rstb.2001.0999","article-title":"The evolution of human influenza viruses","volume":"356","author":"Hay","year":"2001","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.vaccine.2022.03.065_b0050","article-title":"Burden, effectiveness and safety of influenza vaccines in elderly, paediatric and pregnant populations","volume":"7","author":"Sullivan","year":"2019","journal-title":"Ther Adv Vaccines Immunother"},{"key":"10.1016\/j.vaccine.2022.03.065_b0055","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.vaccine.2004.08.044","article-title":"Population-wide benefits of routine vaccination of children against influenza","volume":"23","author":"Weycker","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.03.065_b0060","doi-asserted-by":"crossref","first-page":"5321","DOI":"10.1016\/j.vaccine.2008.06.101","article-title":"Estimating the impact of childhood influenza vaccination programmes in England and Wales","volume":"26","author":"Vynnycky","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.03.065_b0065","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.vaccine.2011.11.106","article-title":"Estimating the clinical impact of introducing paediatric influenza vaccination in England and Wales","volume":"30","author":"Pitman","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.03.065_b0070","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1471-2334-14-40","article-title":"The epidemiological impact of childhood influenza vaccination using live-attenuated influenza vaccine (LAIV) in Germany: predictions of a simulation study","volume":"14","author":"Rose","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2022.03.065_b0075","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s40258-016-0296-4","article-title":"Assessment of public health and economic impact of intranasal live-attenuated influenza vaccination of children in france using a dynamic transmission model","volume":"15","author":"Gerlier","year":"2017","journal-title":"Appl Health Econ Health Policy"},{"key":"10.1016\/j.vaccine.2022.03.065_b0080","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.epidem.2018.10.001","article-title":"The impact of influenza vaccination on infection, hospitalisation and mortality in the Netherlands between 2003 and 2015","volume":"26","author":"Backer","year":"2019","journal-title":"Epidemics"},{"key":"10.1016\/j.vaccine.2022.03.065_b0085","doi-asserted-by":"crossref","first-page":"7554","DOI":"10.1016\/j.vaccine.2011.08.015","article-title":"Cost-effectiveness and socio-economic aspects of childhood influenza vaccination","volume":"29","author":"Nichol","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.03.065_b0090","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.healthpol.2007.09.009","article-title":"Economic evidence of influenza vaccination in children","volume":"86","author":"Savidan","year":"2008","journal-title":"Health Policy"},{"key":"10.1016\/j.vaccine.2022.03.065_b0095","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0140-6736(73)93062-6","article-title":"Controlled trial of inactivated influenza vaccine containing the a-Hong Kong strain during an outbreak of influenza due to the a-England-42-72 strain","volume":"2","author":"Hoskins","year":"1973","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2022.03.065_b0100","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0140-6736(76)93151-2","article-title":"Influenza at Christ\u2019s Hospital: March, 1974","volume":"1","author":"Hoskins","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2022.03.065_b0105","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0140-6736(79)90468-9","article-title":"Assessment of inactivated influenza A vaccine after three outbreaks of influenza A at Christ\u2019s Hospital","volume":"313","author":"Hoskins","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2022.03.065_b0110","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12916-017-0919-0","article-title":"The impact of repeated vaccination on influenza vaccine effectiveness: a systematic review and meta-analysis","volume":"15","author":"Ramsay","year":"2017","journal-title":"BMC Med"},{"key":"10.1016\/j.vaccine.2022.03.065_b0115","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/S0264-410X(97)00003-0","article-title":"Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period","volume":"15","author":"Keitel","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.03.065_b0120","doi-asserted-by":"crossref","first-page":"14001","DOI":"10.1073\/pnas.96.24.14001","article-title":"Variable efficacy of repeated annual influenza vaccination","volume":"96","author":"Smith","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2022.03.065_b0125","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1001\/archinte.159.2.182","article-title":"Protection against influenza after annually repeated vaccination: a meta-analysis of serologic and field studies","volume":"159","author":"Beyer","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.vaccine.2022.03.065_b0130","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.vaccine.2013.11.060","article-title":"Influenza vaccination and risk of hospitalization among adults with laboratory confirmed influenza illness","volume":"32","author":"McLean","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.03.065_b0135","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1093\/cid\/ciw544","article-title":"Repeat Influenza Vaccination and High-Dose Efficacy","volume":"63","author":"Skowronski","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2022.03.065_b0140","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1016\/j.vaccine.2020.03.025","article-title":"Negative effect on immune response of repeated influenza vaccination and waning effectiveness in interseason for elderly people","volume":"38","author":"Sugishita","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.03.065_b0145","first-page":"572","article-title":"On the Doctrine of Original Antigenic Sin","volume":"104","author":"Francis","year":"1960","journal-title":"Proc Am Philos Soc"},{"key":"10.1016\/j.vaccine.2022.03.065_b0150","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.coviro.2016.12.004","article-title":"Immune history and influenza virus susceptibility","volume":"22","author":"Cobey","year":"2017","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.vaccine.2022.03.065_b0155","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41591-022-01690-w","article-title":"Influenza virus infection history shapes antibody responses to influenza vaccination","volume":"28","author":"Auladell","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2022.03.065_b0160","doi-asserted-by":"crossref","DOI":"10.3390\/v14030470","article-title":"Opposing Effects of Prior Infection versus Prior Vaccination on Vaccine Immunogenicity against Influenza A(H3N2) Viruses","volume":"14","author":"Fox","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2022.03.065_b0165","doi-asserted-by":"crossref","DOI":"10.1093\/jac\/44.suppl_2.3","article-title":"Epidemiology and pathogenesis of influenza","author":"Zambon","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.vaccine.2022.03.065_b0170","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/s00285-002-0186-2","article-title":"Dynamics of annual influenza A epidemics with immuno-selection","volume":"46","author":"Andreasen","year":"2003","journal-title":"J Math Biol"},{"key":"10.1016\/j.vaccine.2022.03.065_b0175","unstructured":"Fiore AE, Uyeki TM, Broder K, Lyn Finelli D, Gary L. Euler D, James A. Singleton MS, et al. Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 2010;59:1\u201362."},{"key":"10.1016\/j.vaccine.2022.03.065_b0180","article-title":"Seasonal influenza vaccination and antiviral use in EU\/EEA Member States. European Centre for Disease","author":"Mereckiene","year":"2018","journal-title":"Prev Control"},{"key":"10.1016\/j.vaccine.2022.03.065_b0185","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-2288-10-18","article-title":"Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model","volume":"10","author":"Coudeville","year":"2010","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.vaccine.2022.03.065_b0190","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1126\/science.1132745","article-title":"Epochal evolution shapes the phylodynamics of interpandemic influenza A (H3N2) in humans","volume":"314","author":"Koelle","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2022.03.065_b0195","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/1471-2148-11-220","article-title":"Strength and tempo of selection revealed in viral gene genealogies","volume":"11","author":"Bedford","year":"2011","journal-title":"BMC Evol Biol"},{"key":"10.1016\/j.vaccine.2022.03.065_b0200","doi-asserted-by":"crossref","first-page":"6852","DOI":"10.1016\/j.vaccine.2007.07.027","article-title":"Influenza vaccine: the challenge of antigenic drift","volume":"25","author":"Carrat","year":"2007","journal-title":"Vaccine"},{"issue":"Suppl 5","key":"10.1016\/j.vaccine.2022.03.065_b0205","doi-asserted-by":"crossref","first-page":"B40","DOI":"10.1016\/S0264-410X(02)00509-1","article-title":"Selection of influenza vaccine strains and developing pandemic vaccines","volume":"20","author":"Wood","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.03.065_b0210","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/ije\/13.1.87","article-title":"Assessment of the protective efficacy of vaccines against common diseases using case-control and cohort studies","volume":"13","author":"Smith","year":"1984","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.vaccine.2022.03.065_b0215","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/INF.0b013e31806166f8","article-title":"Efficacy and safety of a live attenuated, cold-adapted influenza vaccine, trivalent against culture-confirmed influenza in young children in Asia","volume":"26","author":"Tam","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2022.03.065_b0220","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/cit736","article-title":"Influenza vaccine effectiveness in the 2011\u20132012 season: protection against each circulation virus and the effect of prior vaccination on estimates","volume":"58","author":"Ohmit","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2022.03.065_b0225","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2334-14-480","article-title":"Estimates of the reproduction number for seasonal, pandemic, and zoonotic influenza: a systematic review of the literature","volume":"14","author":"Biggerstaff","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2022.03.065_b0230","doi-asserted-by":"crossref","unstructured":"Truscott J, Fraser C, Hinsley W, Cauchemez S, Donnelly C, Ghani A, et al. Quantifying the transmissibility of human influenza and its seasonal variation in temperate regions. PLoS Curr 2009;1:RRN1125.","DOI":"10.1371\/currents.RRN1125"},{"key":"10.1016\/j.vaccine.2022.03.065_b0235","unstructured":"PHE Influenza Surveillance, Immunisation and Countermeasures, National Infection Service. Seasonal influenza vaccine uptake in GP patients: winter season 2018 to 2019. Public Health England; 2019."},{"key":"10.1016\/j.vaccine.2022.03.065_b0240","first-page":"239","article-title":"A Comparison of Three Methods for Selecting Values of Input Variables in the Analysis of Output from a Computer Code","volume":"21","author":"McKay","year":"1979","journal-title":"Technometrics"},{"key":"10.1016\/j.vaccine.2022.03.065_b0245","unstructured":"R Core Team. R: A language and environment for statistical computing. Vienna, Austria; 2019."},{"key":"10.1016\/j.vaccine.2022.03.065_b0250","unstructured":"Joint Committee on Vaccination and Immunisation. Minute of the meeting held on Friday 13 April 2012 1 -- 4.00 pm 2012."},{"key":"10.1016\/j.vaccine.2022.03.065_b0255","doi-asserted-by":"crossref","first-page":"4934","DOI":"10.1016\/j.vaccine.2006.03.057","article-title":"Cost-effectiveness of influenza vaccination of healthy children","volume":"24","author":"Salo","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.03.065_b0260","unstructured":"Canadian Paediatric Society. Vaccine recommendations for children and youth for the 2020\/2021 influenza season n.d. https:\/\/www.cps.ca\/en\/documents\/position\/vaccine-recommendations-2020-2021-influenza-season#ref1 (accessed June 25, 2021)."},{"key":"10.1016\/j.vaccine.2022.03.065_b0265","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12916-019-1471-x","article-title":"Vaccinating children against influenza: overall cost-effective with potential for undesirable outcomes","volume":"18","author":"de Boer","year":"2020","journal-title":"BMC Med"},{"key":"10.1016\/j.vaccine.2022.03.065_b0270","doi-asserted-by":"crossref","DOI":"10.1038\/d41586-019-01524-9","article-title":"Long-term studies will track indelible marks of first flu","author":"Butler","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2022.03.065_b0275","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.vaccine.2005.08.105","article-title":"Antibody response to influenza vaccination in the elderly: a quantitative review","volume":"24","author":"Goodwin","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.03.065_b0280","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1016\/j.vaccine.2012.03.019","article-title":"Health and economic impact of the seasonal influenza vaccination programme in England","volume":"30","author":"Baguelin","year":"2012","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2200384X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2200384X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:12:47Z","timestamp":1759403567000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2200384X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":56,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0264410X2200384X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.03.065","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.09.22.21263935","asserted-by":"object"}]},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is annual vaccination best? A modelling study of influenza vaccination strategies in children","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.03.065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}